Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 9/20 | 0.50 |
| ▸ | RAB9A | P51151 | 8/20 | 0.50 |
| ▸ | NPC1 | O15118 | 6/20 | 0.50 |
| ▸ | MAPT | P10636 | 5/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | MAOB | P27338 | 1/20 | 0.48 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.47 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.46 |
| ▸ | RELA | Q04206 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6490529 | 0.87 | SMN1; SMN2 (0.46) | SMN1; SMN2RAB9ANPC1MAPTMAPK1 | |
| SCHEMBL6499184 | 0.84 | ALDH1A1 (0.48) | SMN1; SMN2RAB9ANPC1MAPTMAPK1 | |
| SCHEMBL6502928 | 0.83 | SMN1; SMN2 (0.45) | SMN1; SMN2MAPTPOLBL3MBTL1KMT2A | |
| SCHEMBL6493102 | 0.82 | LNPEP (0.49) | RAB9AMAPTKMT2AALDH1A1MEN1 | |
| SCHEMBL11634119 | 0.82 | PKM (0.65) | SMN1; SMN2RAB9ANPC1MAPTMAPK1 | |
| SCHEMBL31556186 | 0.82 | PKM (0.65) | SMN1; SMN2RAB9ANPC1MAPTMAPK1 | |
| SCHEMBL11406573 | 0.79 | KMT2A (0.59) | SMN1; SMN2RAB9ANPC1MAPTMAPK1 | |
| SCHEMBL11235710 | 0.78 | RAB9A (0.66) | SMN1; SMN2RAB9ANPC1MAPTMAPK1 | |
| SCHEMBL11630189 | 0.78 | KMT2A (0.55) | SMN1; SMN2RAB9ANPC1MAPTMAPK1 | |
| SCHEMBL11295618 | 0.78 | MAPT (0.68) | SMN1; SMN2RAB9ANPC1MAPTMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050014812-A1 | Benzimidazole compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2005-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050014812-A1 | Benzimidazole compounds | SLC5A1, SLC5A2, G6PD | SMN1; SMN2 1128/4885RAB9A 2599/4885NPC1 315/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.